Chemotherapy-Induced Alopecia

Seminars in Cutaneous Medicine and Surgery

Volumn 28, Issue 1, 2009, Pages 11-14

  Trüeb, Ralph M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM TRICHLORO(DIOXYETHYLENE O,O')TELLURATE; AMSACRINE; BLEOMYCIN; BUSULFAN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; DERMATOLOGICAL AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; NAVELBINE; PACLITAXEL; THIOTEPA; TOPOTECAN; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; VINDESINE;

ALOPECIA; ANAGEN EFFLUVIUM; CANCER CHEMOTHERAPY; CELL CYCLE ARREST; CELL PROLIFERATION; CHEMOTHERAPY INDUCED ALOPECIA; CLINICAL FEATURE; COOLING; DISEASE SEVERITY; DRUG MEGADOSE; DRUG WITHDRAWAL; EMOTIONAL STRESS; HAIR FOLLICLE; HAIR GROWTH; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SCALP; SKIN TEMPERATURE; TELOGEN EFFLUVIUM;

ALOPECIA; ANTINEOPLASTIC AGENTS; CRYOTHERAPY; HAIR FOLLICLE; HUMANS; MINOXIDIL; VASODILATOR AGENTS;

EID: 63049106236     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2008.12.001     Document Type: Review

References (40)

1. McGarvey E.L., Baum L.D., Pinkerton R.C., et al. Psychological sequelae and alopecia among women with cancer. Cancer Pract 9 (2001) 283-289
2. Mundstedt K., Manthey N., Sachsse S., et al. Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer 5 (1997) 139-143
3. Harrison S., and Sinclair R. Optimal management of hair loss (alopecia) in children. Am J Clin Dermatol 4 (2003) 757-770
4. Batchelor D. Hair and cancer chemotherapy: Consequences and nursing care-A literature study. Eur J Cancer Care 10 (2001) 147-163
5. Dorr V.J. A practioner's guide to cancer-related alopecia. Semin Oncol 25 (1998) 562-570
6. Crounse R.C., and van Scott E.J. Changes in the scalp hair roots as a measure of toxicity from cancer chemotherapeutic drugs. J Invest Dermatol 35 (1960) 83-90
7. Kligman A.M. Pathologic dynamics of human hair loss. Arch Dermatol 83 (1961) 17-198
8. Braun-Falco O. Dynamikdes: Dynamics of normal and pathological hair growth. Arch Klin Exp Dermatol 227 (1966) 418-452
9. Rebora A. Telogen effluvium. Dermatology 195 (1997) 209-212
10. Baker B., Wilson C., Davis A., et al. Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth. Bone Marrow Transplant 7 (1991) 43-47
11. Tran D., Sinclair R.D., Schwarer A.P., et al. Permanent alopecia following chemotherapy and bone marrow transplantation. Austral J Dermatol 41 (2000) 106-108
12. Vowels M., Chan L.L., Giri N., et al. Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transplant 12 (1993) 347-350
13. Yun S.J., and Kim S.-J. Hair loss pattern due to chemotherapy-induced anagen effluvium: A cross-sectional observation. Dermatology 215 (2007) 36-40
14. Wang J., Lu Z., and Au J.L.S. Protection against chemotherapy-induced alopecia. Pharm Res 23 (2006) 2505-2514
15. Grevelman E.G., and Breed W.P.M. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 16 (2005) 352-358
16. Edelstyn G.A., MacDonald M., and MacRae K.D. Doxorubicin-induced hair loss and possible modification by scalp cooling. Lancet II (1977) 253-254
17. Giaccone G., Di Gulio F., Morandini M.P., et al. Scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer Nurs 11 (1988) 170-173
18. Kennedy M., Packard R., Grant M., et al. The effect of using Chemocap on occurrence of chemotherapy-induced alopecia. Oncol Nurs Forum 10 (1983) 19-24
19. Macduff C., Mackenzie T., Hutcheon A., et al. The effectiveness of scalp cooling n preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care 12 (2003) 154-161
20. Parker R. The effectiveness of scalp hypothermia in preventing cyclophosphamide-induced alopecia. Oncol Nurs Forum 14 (1987) 49-53
21. Ron I.G., Kalmus Y., Kalmus Z., et al. Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. Support Care Cancer 5 (1997) 136-138
22. Satterwhite B., and Zimm S. The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer 54 (1984) 34-37
23. Lundgren-Eriksson L., Edborm G., Olofsson Y., et al. Total prevention of taxoid-induced alopecia by a new model of cold cap (dignitana). Eur J Cancer 35 suppl 4 (1999) 376
24. Lemenager M., Lecomte S., Bonneterre M.E., et al. Effectiveness of cold cap in the prevention of docetaxel-induced alopecia. Eur J Cancer 33 (1997) 297-300
25. Hunt J.M., Anderson J.E., and Smith I.E. Scalp hypothermia to prevent Adriamycin-induced hair loss. Cancer Nurs 5 (1982) 25-31
26. Gregory R.P., Cooke T., Middleton J., et al. Prevention of doxorubicin-induced alopecia by scalp hypothermia: Relation to degree of cooling. BMJ 284 (1982) 1674
27. Witman G., Cadman E., and Chen M. Misuse of scalp hypothermia. Cancer Treat Rep 65 (1981) 507-508
28. Forsberg S. Scalp cooling therapy and cytotoxic treatment. Lancet 357 (2001) 1134
29. Ridderheim M., Bjurberg M., and Gustavsson A. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer 11 (2003) 371-377
30. Sredni B., Xu R.H., Albeck M., et al. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models. Int J Cancer 65 (1996) 97-103
31. Duvic M., Lemak N.A., Valero V., et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 35 (1996) 74-78
32. Granai C.O., Frederickson H., Gajewski W., et al. The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies. Eur J Gynaecol Oncol 12 (1991) 129-132
33. Rodriguez R., Machiavelli M., Leone B., et al. Minoxidil as a prophylaxis of doxorubicin-induced alopecia. Ann Oncol 5 (1994) 769-770
34. Van Neste D., de Brouwer B., and Dumortier M. Reduced linear hair growth rates of vellus and of terminal hairs produced by human balding scalp grafted onto nude mice. Ann N Y Acad Sci 642 (1991) 480-482
35. Hussein A.M., Jiminez J.J., McCall C.A., et al. Protection from chemotherapy-induced alopecia in a rat model. Science 249 (1990) 1564-1566
36. Paus R., Handjiski B., Eichmüller S., et al. Chemotherapy-induced alopecia in mice-Induction by cyclophosphamide, inhibition by cyclosporin A, and modulation by dexamethasone. Am J Pathol 144 (1994) 719-734
37. Hidalgo M., Rinaldis D., Media G., et al. A phase I trial of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to prevent chemotherapy-induces alopecia. Anti-cancer Drugs 10 (1999) 393-395
38. Davis S.T., Benson B.G., Bramson H.N., et al. Prevention of chemotherapy-induced alopecia in rats by cdk inhibitors. Science 291 (2001) 134-137
39. Trüeb R.M. Chemotherapy-induced anagen effluvium: Diffuse or patterned?. Dermatology 215 (2007) 1-2
40. Trüeb R.M. Diffuse hair loss. In: Blume-Peytavi U., Tosti A., Whiting D.A., and Trüeb R. (Eds). Hair Growth and Disorders (2008), Springer Verlag, Berlin 259ff